SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-17-054858
Filing Date
2017-10-30
Accepted
2017-10-30 17:00:09
Documents
1
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 tv478052_sc13da1.htm SC 13D/A 101447
  Complete submission text file 0001144204-17-054858.txt   103239
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50211 | Film No.: 171163068
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A